These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 22864646)

  • 1. Novel immune signals and atherosclerosis.
    Iwata H; Nagai R
    Curr Atheroscler Rep; 2012 Oct; 14(5):484-90. PubMed ID: 22864646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A glimpse on the phenomenon of macrophage polarization during atherosclerosis.
    Pello OM; Silvestre C; De Pizzol M; Andrés V
    Immunobiology; 2011 Nov; 216(11):1172-6. PubMed ID: 21802768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocytes in coronary artery disease and atherosclerosis: where are we now?
    Ghattas A; Griffiths HR; Devitt A; Lip GY; Shantsila E
    J Am Coll Cardiol; 2013 Oct; 62(17):1541-51. PubMed ID: 23973684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.
    Horio E; Kadomatsu T; Miyata K; Arai Y; Hosokawa K; Doi Y; Ninomiya T; Horiguchi H; Endo M; Tabata M; Tazume H; Tian Z; Takahashi O; Terada K; Takeya M; Hao H; Hirose N; Minami T; Suda T; Kiyohara Y; Ogawa H; Kaikita K; Oike Y
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):790-800. PubMed ID: 24526691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage: A Key Therapeutic Target in Atherosclerosis?
    Taghizadeh E; Taheri F; Renani PG; Reiner Ž; Navashenaq JG; Sahebkar A
    Curr Pharm Des; 2019; 25(29):3165-3174. PubMed ID: 31470780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Toll like receptor signaling pathway in ischemic coronary artery disease.
    Satoh M; Ishikawa Y; Minami Y; Takahashi Y; Nakamura M
    Front Biosci; 2008 May; 13():6708-15. PubMed ID: 18508689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophages heterogeneity in atherosclerosis - implications for therapy.
    Wilson HM
    J Cell Mol Med; 2010 Aug; 14(8):2055-65. PubMed ID: 20629993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial extracellular vesicles modulate the macrophage phenotype: Potential implications in atherosclerosis.
    He S; Wu C; Xiao J; Li D; Sun Z; Li M
    Scand J Immunol; 2018 Apr; 87(4):e12648. PubMed ID: 29465752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunobiology of Atherosclerosis: A Complex Net of Interactions.
    Herrero-Fernandez B; Gomez-Bris R; Somovilla-Crespo B; Gonzalez-Granado JM
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocyte fate in atherosclerosis.
    Hilgendorf I; Swirski FK; Robbins CS
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):272-9. PubMed ID: 25538208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porphyromonas gingivalis mediated periodontal disease and atherosclerosis: disparate diseases with commonalities in pathogenesis through TLRs.
    Gibson FC; Genco CA
    Curr Pharm Des; 2007; 13(36):3665-75. PubMed ID: 18220804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monocyte-Macrophages and T Cells in Atherosclerosis.
    Tabas I; Lichtman AH
    Immunity; 2017 Oct; 47(4):621-634. PubMed ID: 29045897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is monocyte- and macrophage-derived tissue transglutaminase involved in inflammatory processes?
    Chrobok NL; Sestito C; Wilhelmus MM; Drukarch B; van Dam AM
    Amino Acids; 2017 Mar; 49(3):441-452. PubMed ID: 27659795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocyte and macrophage immunometabolism in atherosclerosis.
    Groh L; Keating ST; Joosten LAB; Netea MG; Riksen NP
    Semin Immunopathol; 2018 Feb; 40(2):203-214. PubMed ID: 28971272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The involvement of the monocytes/macrophages in chronic inflammation associated with atherosclerosis.
    Fenyo IM; Gafencu AV
    Immunobiology; 2013 Nov; 218(11):1376-84. PubMed ID: 23886694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory cell recruitment in cardiovascular disease: murine models and potential clinical applications.
    McNeill E; Channon KM; Greaves DR
    Clin Sci (Lond); 2010 Mar; 118(11):641-55. PubMed ID: 20210786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptors and macrophage activation in atherosclerosis.
    Seneviratne AN; Sivagurunathan B; Monaco C
    Clin Chim Acta; 2012 Jan; 413(1-2):3-14. PubMed ID: 21884686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of soluble epoxide hydrolase alleviated atherosclerosis by reducing monocyte infiltration in Ldlr(-/-) mice.
    Li D; Liu Y; Zhang X; Lv H; Pang W; Sun X; Gan LM; Hammock BD; Ai D; Zhu Y
    J Mol Cell Cardiol; 2016 Sep; 98():128-37. PubMed ID: 27496380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective.
    Mallika V; Goswami B; Rajappa M
    Angiology; 2007; 58(5):513-22. PubMed ID: 18024933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunometabolism orchestrates training of innate immunity in atherosclerosis.
    van Tuijl J; Joosten LAB; Netea MG; Bekkering S; Riksen NP
    Cardiovasc Res; 2019 Jul; 115(9):1416-1424. PubMed ID: 31050710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.